Yazan J. Meqbil
banner
yazmeq.bsky.social
Yazan J. Meqbil
@yazmeq.bsky.social
Molecular Pharmacologist automating the intersections of HTS, molecular modeling, and molecular pharmacology | San Francisco Bay Area
Reposted by Yazan J. Meqbil
Must read!
Intracellular GPCR modulators enable precision pharmacology
www.nature.com/articles/s44...
Intracellular GPCR modulators enable precision pharmacology - npj Drug Discovery
npj Drug Discovery - Intracellular GPCR modulators enable precision pharmacology
www.nature.com
May 12, 2025 at 7:27 PM
Reposted by Yazan J. Meqbil
We wrote this Neuroview to get the word out about the extremely exciting and important NIH funded work happening in the pain field and how it has the potential to really change pain treatment in the coming years www.cell.com/neuron/fullt... We did not imagine how rapidly things would be dismantled.
Human pain neuroscience and the next generation of pain therapeutics
The recent approval of suzetrigine for acute pain treatment highlights both the success of targeting peripheral sensory neurons for pain management and the potential of developing new pain therapies p...
www.cell.com
May 11, 2025 at 2:27 AM
Amazing indeed! This method tracks single molecules escaping nanoscale traps to reveal size, shape, and conformational states in solution. Hats off to the authors for an outstanding advancement.
May 10, 2025 at 2:25 AM
Reposted by Yazan J. Meqbil
The first paper from my PhD has been published!

Insights on Psychedelics: A Systematic Review of Therapeutic Effects
www.sciencedirect.com/science/arti...
Insights on psychedelics: A systematic review of therapeutic effects
Insight – a sudden change in understanding or perspective that feels true or reliable – is a common occurrence during psychedelic experiences, and oft…
www.sciencedirect.com
April 28, 2025 at 9:35 AM
Exciting news from our team here at Vilya! RFpeptides is an RFdiffusion-based DL pipeline for designing macrocyclic peptides. Exclusively licensed to Vilya🔥

It’s an exciting time to at the forefront of the macrocyclic peptide drug discovery space.

Preprint:

www.biorxiv.org/content/10.1...
November 21, 2024 at 7:39 PM
Congrats @tastelabhuji.bsky.social and team!
November 21, 2024 at 12:26 AM
Another day, another excellent database.

I’ve been an avid and grateful user of GPCRdb, GPCRmd, and other databases, all of which keep getting better. I’m excited to try this one!

academic.oup.com/nar/advance-...
PGxDB: an interactive web-platform for pharmacogenomics research
Abstract. Pharmacogenomics, the study of how an individual's genetic makeup influences their response to medications, is a rapidly evolving field with sign
academic.oup.com
November 21, 2024 at 12:25 AM
Reposted by Yazan J. Meqbil
This is amazing! @shervinnia.bsky.social resurrected our cryoEM-papers bot. At it's peak we had over 12k followers on Twitter, but the bot became defunct by a silly Musk policy (and it all went downhill from there).
If you want to keep up with #cryoEM papers, follow:
cryoempapers.bsky.social
cryoEM papers (@cryoempapers.bsky.social)
Operated by @shervinnia.bsky.social and inspired by the now-defunct bot by Frédéric Poitevin and @gati.bsky.social. Suggestions welcome.
cryoempapers.bsky.social
November 20, 2024 at 3:54 PM
Another paper from the Van Rijn and Riley labs on natural product-derived agonists for the kappa opioid receptors.

pubs.acs.org/doi/10.1021/...
Discovery of Potent Kappa Opioid Receptor Agonists Derived from Akuammicine
Akuammicine (1), an alkaloid isolated from Picralima nitida, is an agonist of the kappa opioid receptor (κOR). To establish structure–activity relationships (SARs) for this structurally unique κOR lig...
pubs.acs.org
November 20, 2024 at 5:37 PM
Reposted by Yazan J. Meqbil
A first attempt to assemble GPCR aficionados here on 🦋 Let me know who I missed by replying below!

go.bsky.app/75ukb81
November 16, 2024 at 6:05 PM
It feels so good to be back! #sci-twitter was good but I hope #sci-sky will be better!

#science #gpcr #drugdiscovery
November 16, 2024 at 5:55 PM